Pell Bio-Med Technology Balance Sheet Health
Financial Health criteria checks 6/6
Pell Bio-Med Technology has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.8B and NT$335.0M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$1.42b |
Equity | NT$1.47b |
Total liabilities | NT$335.01m |
Total assets | NT$1.80b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6949's short term assets (NT$1.4B) exceed its short term liabilities (NT$200.4M).
Long Term Liabilities: 6949's short term assets (NT$1.4B) exceed its long term liabilities (NT$134.6M).
Debt to Equity History and Analysis
Debt Level: 6949 is debt free.
Reducing Debt: 6949 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6949 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6949 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 17.4% each year